Works matching IS 21989788 AND DT 2022 AND VI 9 AND IP 2

Results: 13
    1

    Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS).

    Published in:
    Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 231, doi. 10.1007/s40801-022-00300-y
    By:
    • Zhao, Ying;
    • Zhang, Jingru;
    • Zheng, Kai;
    • Thai, Sydney;
    • Simpson Jr., Ross J.;
    • Kinlaw, Alan C.;
    • Xu, Yang;
    • Wei, Jingkai;
    • Cui, Xiangli;
    • Buse, John B;
    • Stürmer, Til;
    • Wang, Tiansheng
    Publication type:
    Article
    2
    3
    4

    Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer.

    Published in:
    Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 275, doi. 10.1007/s40801-022-00294-7
    By:
    • Holleman, Marscha S.;
    • Huygens, Simone A.;
    • Al, Maiwenn J.;
    • Kuppen, Malou C. P.;
    • Westgeest, Hans M.;
    • van den Bergh, Alfonsus C. M.;
    • Bergman, Andries M.;
    • van den Eertwegh, Alfonsus J. M.;
    • Hendriks, Mathijs P.;
    • Lampe, Menuhin I.;
    • Mehra, Niven;
    • van Moorselaar, Reindert J. A.;
    • van Oort, Inge M.;
    • Somford, Diederik M.;
    • de Wit, Ronald;
    • van de Wouw, Agnes J.;
    • Gerritsen, Winald R.;
    • Groot, Carin A. Uyl-de
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13